LINC02802 and lung carcinoma: Given that LINC02802 regulates the mitochondrial NAD+/NADH ratio, and mitochondrial metabolism is closely intertwined with immune cell activation and function, it is plausible that the tumor immune microenvironment (TIME) may contribute to the upregulation of LINC02802 in lung cancer.